The Behavioral and Emotional Rating Scale: Long Term Test-Retest Reliability

2001 ◽  
Vol 26 (4) ◽  
pp. 314-320 ◽  
Author(s):  
Michael H. Epstein ◽  
Melody A. Hertzog ◽  
Robert Reid
Keyword(s):  
General Education ◽  
Rating Scale ◽  
Time Frame ◽  
Assessment Instrument ◽  
Retest Reliability ◽  
Strength Based ◽  
Report Data ◽  
Test Retest Reliability ◽  
Emotional Rating

Most assessment is conducted from a deficit perspective and is intended to identify deficits, problems, and pathologies of the individuals who are assessed. However, deficit-based assessment may present a biased picture that limits or ignores a child's strengths. In this article we report data on long-term (6-month) test-retest reliability of the Behavior and Emotional Rating Scale (BERS), which is a strength-based assessment instrument. Participants included 95 randomly selected children from general education classrooms and 26 children identified as having or being at risk for emotional or behavioral disorders. Moderate to high test-retest correlations ranging from .527 to .787 were found across the instrument's subscales. Moreover, the lack of significant differences between ratings indicate that rater drift did not occur. Results suggest that BERS scores are stable over a 6-month time frame. Implications for the use of the BERS are discussed.

scholarly journals Psychometric Evaluation of the Persian Version of Barkley Adult Attention Deficit/Hyperactivity Disorder Screening Tool among the Elderly

Scientifica ◽  
2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Mostafa Sadeghi ◽  
Homayoun Sadeghi-Bazargani ◽  
Shahrokh Amiri
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Internal Consistency ◽  
Attention Deficit ◽  
Concurrent Validity ◽  
Rating Scale ◽  
Retest Reliability ◽  
Hyperactivity Disorder ◽  
Persian Version ◽  
Test Retest Reliability ◽  
Tabriz City

Background. The Barkley Adult Attention Deficit/Hyperactivity Disorder (ADHD) Rating Scale-IV (BAARS-IV) was developed, and it demonstrated good psychometric properties. The BAARS-IV includes 27 questions on the symptoms of adult ADHD. The purpose of the present study is to investigate the psychometric testing of the Persian version of BAARS-IV among the elderlies in Tabriz City. Method. This cross-sectional study was conducted in Tabriz City—in the west of Iran—in 2015 via enrolling of 121 old-aged people. We did the process of translation and adaptation of BAARS-IV and examined its concurrent validity, internal consistency, and test-retest reliability. Result. The BAARS-IV demonstrated good internal consistency and test-retest reliability. Correlations between the BAARS-IV and the CAARS-S: SV were high and evidence supporting concurrent validity was revealed. Cronbach’s alpha for the overall scale and subscales stood at 0.89, 0.81, 0.66, 0.56, and 0.82, respectively. Conclusion. The Persian BAARS-IV showed acceptable reliability and validity. BAARS-IV was determined to be composed of internally consistent and psychometrically sound items.

The TAPS Project. 9: The Reliability of the Patient Attitude Questionnaire

1993 ◽  
Vol 162 (S19) ◽  
pp. 25-29 ◽  
Author(s):  
Graham Thornicroft ◽  
Christopher Gooch ◽  
Catherine O'Driscoll ◽  
Sawsan Reda
Keyword(s):  
Living Arrangements ◽  
Psychiatric Patients ◽  
Kappa Coefficient ◽  
Attitudinal Change ◽  
Attitude Questionnaire ◽  
Retest Reliability ◽  
Patient Attitude ◽  
The Mean ◽  
Test Retest Reliability

The development of the hospital and community versions of the Patient Attitude Questionnaire is described. The instrument rates the attitudes of psychiatric patients towards their treatment settings and staff, and is framed specifically to assess attitudinal change during the transfer of patients from hospital. For the items rated using the kappa coefficient of agreement, the mean test-retest reliability value was 0.51, and the average inter-rater value was 0.82. This study shows that long-term psychiatric patients are able to give clear and consistent views about their living arrangements - views that should be sought and respected by staff.

Long-term use of nonsteroidal anti-inflammatory drugs for pain control in patients with osteoarthritis: results of the 12-month observational study AELITA (Analgesia: Effective Treatment Using The Therapeutic Algorithm)

2021 ◽  
Vol 15 (6) ◽  
pp. 84-90
Author(s):  
A. E. Karateev ◽  
E. Yu. Polishchuk ◽  
E. S. Filatova ◽  
A. S. Potapova ◽  
V. A. Nesterenko ◽  
...  
Keyword(s):  
Pain Control ◽  
Rating Scale ◽  
Health Assessment ◽  
Pain Reduction ◽  
Time Frame ◽  
Number Of Patients ◽  
Primary Means ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Non-steroidal anti-inflammatory drugs (NSAIDs) are the primary means of managing chronic osteoarthritis (OA) pain. The choice of NSAIDs is based on an analysis of the risk of adverse reactions (ARs). Objective: to evaluate the efficacy and safety of long-term use of NSAIDs for pain control in patients with OA in real clinical practice.Patients and methods. To assess the results of long-term use of NSAIDs in OA, a 12-month observational non-interventional study was conducted. It included 611 patients with knee, hip and generalized OA, and nonspecific back pain associated with OA of the facet joints. All patients were prescribed aceclofenac (Aertal®) 200 mg/day. The patients' condition was assessed 2 weeks, 3, 6, 9 and 12 months after the start of therapy. The following parameters were determined: the intensity of pain during movement and the general health assessment (GA) according to the visual analogue scale (VAS, 10 cm); pain intensity according to the Likert verbal rating scale (VRS) (0–4); the number of patients with a pain reduction of ≥50% from baseline; patients' assessment of the result of therapy according to Likert VRS (1–5). The development of ARs was recorded at each visit.Results and discussion. By month 12, 46.8% of patients had dropped out of observation. In patients who continued the study, the average severity of pain according to the VAS at baseline, after 2 weeks, 3, 6, 9 and 12 months was: 6.5±1.2; 4.8±1.4; 3.2±1.4; 2.6±1.4; 2.2±1.1; 1.4±1.1 cm, respectively (significant differences compared to the baseline for all points – p<0.05). The same differences were obtained in GA assessment.Within the indicated time frame, the number of patients with moderate / severe pain (on the Likert scale) decreased from 77.8 to 24.9; 2.9; 2.3; 0.9 and 0%, respectively. The number of patients with a pain reduction of ≥50% from baseline was 12.0; 65.1; 81.0; 88.5 and 84.0%, respectively. A good or excellent assessment of treatment results after 2 weeks was given by 63.3% of patients, and after 12 months – by 95.6%. ARs were observed in about 30% of patients, mainly mild or moderate dyspepsia (in 11.1–23.3%) and arterial hypertension (in 7.1–10.9%). No serious ARs were registered.Conclusion. Aceclofenac is an effective and relatively safe drug for the long-term management of chronic pain in OA.

Reliability of a conductive education rating scale for assessing children with multiple disabilities

1994 ◽  
Vol 11 (2) ◽  
pp. 12-17
Author(s):  
Jeff Sigafoos ◽  
Donna Couzens ◽  
Stephanie Gunn
Keyword(s):  
Interobserver Agreement ◽  
Rating Scale ◽  
Multiple Disabilities ◽  
Intelligence Tests ◽  
Adaptive Behaviour ◽  
Education Programs ◽  
Retest Reliability ◽  
Test Retest Reliability

ABSTRACTAdaptive behaviour scales represent an alternative to standardised intelligence tests for assessing children with multiple disabilities. The purpose of the present study was to evaluate the reliability of an adaptive behaviour scale used in Hungarian Conductive Education programs for children with neurological impairments. Forty-five children with multiple disabilities were assessed on two separate occasions by their teachers and physiotherapists. Scores were compared across raters (interobserver agreement) and across the two assessment occasions (test-retest reliability). Interobserver agreement averaged 55.5%, and the overall test-retest reliability was 75%. Suggestions for improving interobserver agreement and test-retest reliability are discussed.

Sign in / Sign up

Export Citation Format

Share Document